SecBot SecBot

ADVB

Advanced Biomed Inc.
Nasdaq· Services-Medical Laboratories· Inc. NV· CIK 0001941029 Healthcare & Medical Devices
$3.17 −0.29 (−8.38%)
Oct 23 4:00 PM ET · prev $3.46
Market cap
$5.7M
Nano cap
1 year
−64.5%
from $8.92 · Oct 24
30 days
−49.8%
from $6.31
52-week range
$3.17–18.98
at the low
Avg volume 20D
38.6K
Oct 19 spike 402.8K
Short interest
18.9K
≈1.1% of shares · +92.0%
Days to cover
1.0
at average volume
Insider net
$0
no open-market trades · 12 mo
Filing reports
3
analyzed by SecBot
SecBot read MIXED 1 report · 90 days
Balance 0 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 1/1 ·Next Earnings date, Nov 17, 2026

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.

  • Short sellersBUILDING

    Short interest +92.0% to 18.9K shares. 1.0 days to cover, ≈1.1% of shares.

  • TrendDOWNTREND

    55% below its 50-day average. New closing low $3.17 on Oct 23.

Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 19, 2026 Trading halt
Halt Resumed: ADVB — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-10-19T15:01:54.000Z | Resumed 2026-10-19T15:06:54.000Z
Sep 22, 2026 SEC
Advance On Ventures Ltd and its director Chen Yi Lee filed a Schedule 13G disclosing a combined 7.5% beneficial…
SC 13G — Impact 3/10
Jul 27, 2026 Insider
Pau Hung To disposed of 76,225 shares
10%+ Owner @ $480,000.00 ($36.6B)
Jul 27, 2026 Insider
Pau Hung To disposed of 100,000 shares
10%+ Owner @ $480,000.00 ($48.0B)
Jul 17, 2026 SEC
Advanced Biomed terminated its $25M equity line of credit (ELOC) with Helena Global Investment Opportunities I Ltd…
8-K — Impact 3/10
Jul 3, 2026 SEC
Advanced Biomed Inc. (ADVB) agreed to sell 100% of its Taiwan subsidiary, which houses its biomedical R&D operations…
8-K — Impact 5/10

Insider ledger

Form 4
$0
open-market buys or sells · 12 mo
DateInsiderTypeValue
Jul 27, 2026
Pau Hung To
10%+ Owner
OTHER$36.6B
Jul 27, 2026
Pau Hung To
10%+ Owner
OTHER$48.0B

Earnings setup

Estimates

Revision history: 🔒 Fresh data — subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data — subscribers only
Next Q🔒 Fresh data — subscribers only
Current FY🔒 Fresh data — subscribers only
Next FY🔒 Fresh data — subscribers only

Short side

FINRA· Sep 30, 2026
18,897
shares short
+92.0%
vs prior settlement
1.0
days to cover
≈1.1%
of shares outstanding
Trading halts
Oct 19, 2026Volatility PauseResumed
Jul 30, 2026Volatility PauseResumed
Jul 27, 2026Volatility PauseResumed
Jul 24, 2026Volatility PauseResumed
Jul 23, 2026Volatility PauseResumed
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 17, 2026
Earnings date
🔒 Fresh data — subscribers only
Recent

SecBot reports

3 filings · 0 bullish · 1 bearish · 2 neutral
All ADVB filing & press-release reports (3)